SEC Tracker
Get the app

Plus Therapeutics CNSY

Plus Therapeutics: quarterly report for the quarter ended Mar 31, 2023

Form
10-Q
Filed
Period
Importance
Notable
Document
10-Q

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Plus Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (3841) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. Femasys FEMY public float $30M, Jun 30, 2025
  2. DarioHealth DRIO public float $28M, Jun 30, 2025
  3. HeartBeam BEAT public float $36M, Jun 30, 2025
  4. Nephros NEPH public float $27M, Jun 30, 2025
  5. RenovoRx RNXT public float $27M, Jun 30, 2025